153.50
0.04 (0.03%)
| Previous Close | 153.46 |
| Open | 151.64 |
| Volume | 419,783 |
| Avg. Volume (3M) | 179,390 |
| Market Cap | 5,513,919,488 |
| Price / Earnings (TTM) | 92.47 |
| Price / Sales | 6.02 |
| Price / Book | 7.44 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Profit Margin | 6.52% |
| Operating Margin (TTM) | 14.34% |
| Diluted EPS (TTM) | 1.66 |
| Quarterly Revenue Growth (YOY) | 10.30% |
| Quarterly Earnings Growth (YOY) | -9.60% |
| Total Debt/Equity (MRQ) | 69.29% |
| Current Ratio (MRQ) | 2.79 |
| Operating Cash Flow (TTM) | 135.94 M |
| Levered Free Cash Flow (TTM) | 95.36 M |
| Return on Assets (TTM) | 5.34% |
| Return on Equity (TTM) | 8.67% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (US) | Bullish | Bullish |
| Scientific & Technical Instruments (Global) | Bullish | Bullish | |
| Stock | Novanta Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | 1.5 |
| Price Volatility | 4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 1.00 |
|
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Small Growth |
| % Held by Insiders | 0.80% |
| % Held by Institutions | 103.73% |
| 52 Weeks Range | ||
| Median | 169.00 (10.10%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 06 Nov 2024 | 169.00 (10.10%) | Hold | 181.94 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 19 Dec 2024 | Announcement | Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025 |
| 18 Dec 2024 | Announcement | Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025 |
| 05 Nov 2024 | Announcement | Novanta Announces Financial Results for the Third Quarter 2024 |
| 15 Oct 2024 | Announcement | Novanta to Present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024 |
| 08 Oct 2024 | Announcement | Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |